Since the start of 2015, the number of large upside moves by biotech stocks is greater than in any period I can recall since the circa 2000 bubble era. It’s somewhat worrisome, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.